Proton-pump inhibitors as a protective treatment for high-risk patients receiving treatment with NSAIDs
- 23 October 2007
- journal article
- editorial
- Published by Springer Nature in Nature Clinical Practice Rheumatology
- Vol. 3 (12) , 694-695
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Gastrointestinal Safety of Cyclooxygenase-2 Inhibitors: A Cochrane Collaboration Systematic ReviewClinical Gastroenterology and Hepatology, 2007
- Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trialThe Lancet, 2007
- Effect of Antisecretory Drugs and Nitrates on the Risk of Ulcer Bleeding Associated With Nonsteroidal Anti-Inflammatory Drugs, Antiplatelet Agents, and AnticoagulantsAmerican Journal of Gastroenterology, 2007
- Celecoxib versus Diclofenac and Omeprazole in Reducing the Risk of Recurrent Ulcer Bleeding in Patients with ArthritisNew England Journal of Medicine, 2002
- Preventing Recurrent Upper Gastrointestinal Bleeding in Patients withHelicobacter pyloriInfection Who Are Taking Low-Dose Aspirin or NaproxenNew England Journal of Medicine, 2001